Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Strecker, Jan Kolja ^a   Minnerup, Jens ^a   Gess, Burkhard ^a   Ringelstein, E Bernd ^a   Schäbitz, Wolf Rüdiger ^a,b   Schilling, Matthias ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN ISCHEMIA; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; GRANULOCYTE; MALE; MOLECULAR DYNAMICS; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STROKE; T LYMPHOCYTE; UPREGULATION; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; METABOLISM; MOUSE MUTANT; REAL TIME POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; BRAIN ISCHEMIA; CHEMOKINE CCL2; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; INTERLEUKIN-6; LASER CAPTURE MICRODISSECTION; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054840927     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025863     Document Type: Article

References (40)

1. Lin N, Friedlander RM, (2009) T-cell activation in ischemic stroke: a new therapeutic target for delayed infarct expansion? Neurosurgery 65 (6): N13.
2. Kriz J, Lalancette-Hébert M, (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117 (5): 497-509.
3. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, et al. (2009) Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40 (5): 1849-57.
4. Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, et al. (2002) Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 22 (1): 38-43.
5. Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, et al. (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115 (8): 2083-98.
6. Schilling M, Strecker JK, Schäbitz WR, Ringelstein EB, Kiefer R, (2009) Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 161 (3): 806-12.
7. Haile WB, Echeverry R, Wu J, Yepes M, (2010) The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain. J Cereb Blood Flow Metab 30 (6): 1147-56.
8. Che X, Ye W, Panga L, Wu DC, Yang GY, (2001) Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 902 (2): 171-7.
9. Deng YY, Lu J, Ling EA, Kaur C, (2009) Monocyte chemoattractant protein-1 (MCP-1) produced via NF-kappaB signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats. Glia 57 (6): 604-21.
10. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, et al. (2002) Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 22 (3): 308-17.
11. Chen Y, Hallenbeck JM, Ruetzler C, et al. (2003) Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 23 (6): 748-55.
12. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, et al. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187 (4): 601-8.
13. Hata R, Mies G, Wiessner C, (1998) A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18 (4): 367-75.
14. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (9): e45.
15. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30 (9): e36.
16. Pekny M, Nilsson M, (2005) Astrocyte activation and reactive gliosis. Glia 50 (4): 427-34.
17. Minnerup J, Sevimli S, Schäbitz WR, (2009) Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med 1: 2.
18. Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, et al. (2005) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115 (8): 2083-98.
19. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA, (2000) Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20 (2): 306-15.
20. Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, et al. (2000) Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31 (7): 1715-20.
21. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, et al. (2003) Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34 (8): 1864-9.
22. Montaner J, Rovira A, Molina CA, Arenillas JF, Ribó M, et al. (2003) Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 23 (12): 1403-7.
23. Yamashita T, Sawamoto K, Suzuki S, Suzuki N, Adachi K, et al. (2005) Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem 94 (2): 459-68.
24. Watanabe S, Mu W, Kahn A, Jing N, Li JH, et al. (2004) Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells. Am J Nephrol 24 (4): 387-92.
25. Potula HS, Wang D, Quyen DV, Nikhlesh KS, Venkatesh KS, et al. (2009) Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. J Biol Chem 284 (45): 31142-55.
26. Loddick SA, Rothwell NJ, (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 16 (5): 932-40.
27. Bowen KK, Naylor M, Vemuganti R, (2006) Prevention of inflammation is a mechanism of preconditioning-induced neuroprotection against focal cerebral ischemia. Neurochem Int 49 (2): 127-35.
28. Shin JA, Park EM, Choi JS, Seo SM, Kang JL, et al. (2009) Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J Neuroimmunol 217 (1-2): 14-9.
29. Samavati L, Rastogi R, Du W, Hüttemann M, Fite A, et al. (2009) STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol 46 (8-9): 1867-77.
30. Gibson CL, Jones NC, Prior MJ, Bath PM, Murphy SP, (2005a) G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J Neuropathol Exp Neurol 64 (9): 763-9.
31. Gibson CL, Bath PM, Murphy SP, (2010) G-CSF administration is neuroprotective following transient cerebral ischemia even in the absence of a functional NOS-2 gene. J Cereb Blood Flow Metab 30 (4): 739-43.
32. Gibson CL, Bath PM, Murphy SP, (2005b) G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25 (4): 431-9.
33. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, et al. (1994) Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84: 1737-1746.
34. McColl BW, Rothwell NJ, Allan SM, (2007) Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci 27 (16): 4403-12.
35. Sevimli S, Diederich K, Strecker JK, Schilling M, Klocke R, et al. (2009) Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol 217 (2): 328-35.
36. Murikinati S, Jüttler E, Keinert T, Ridder DA, Muhammad S, et al. (2010) Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J 24 (3): 788-98.
37. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, et al. (2008) Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 39 (2): 355-60.
38. Gautier S, Ouk T, Petrault O, Caron J, Bordet R, (2009) Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia. Br J Pharmacol 156 (4): 673-9.
39. Yilmaz G, Arumugam TV, Stokes KY, Granger DN, (2006) Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113 (17): 2105-12.
40. Gee JM, Kalil A, Shea C, Becker KJ, (2007) Lymphocytes: potential mediators of postischemic injury and neuroprotection. Stroke 38 (2 Suppl): 783-8.